GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Psyence Biomedical Ltd (NAS:PBM) » Definitions » Price-to-Owner-Earnings

Psyence Biomedical (Psyence Biomedical) Price-to-Owner-Earnings : (As of Apr. 28, 2024)


View and export this data going back to 2024. Start your Free Trial

What is Psyence Biomedical Price-to-Owner-Earnings?

As of today (2024-04-28), Psyence Biomedical's share price is $0.8589. Psyence Biomedical does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Psyence Biomedical's Price-to-Owner-Earnings or its related term are showing as below:


PBM's Price-to-Owner-Earnings is not ranked *
in the Biotechnology industry.
Industry Median: 31.62
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-04-28), Psyence Biomedical's share price is $0.8589. Psyence Biomedical does not have enough years/quarters to calculate the Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2023. Therefore GuruFocus does not calculate PE Ratio at this moment.

As of today (2024-04-28), Psyence Biomedical's share price is $0.8589. Psyence Biomedical does not have enough years/quarters to calculate the EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2023. Therefore GuruFocus does not calculate PE Ratio without NRI at this moment.


Psyence Biomedical Price-to-Owner-Earnings Historical Data

The historical data trend for Psyence Biomedical's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Psyence Biomedical Price-to-Owner-Earnings Chart

Psyence Biomedical Annual Data
Trend Mar21 Mar22 Mar23
Price-to-Owner-Earnings
- - -

Psyence Biomedical Semi-Annual Data
Mar21 Mar22 Mar23
Price-to-Owner-Earnings - - -

Competitive Comparison of Psyence Biomedical's Price-to-Owner-Earnings

For the Biotechnology subindustry, Psyence Biomedical's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Psyence Biomedical's Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Psyence Biomedical's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Psyence Biomedical's Price-to-Owner-Earnings falls into.



Psyence Biomedical Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Psyence Biomedical's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=0.8589/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Psyence Biomedical  (NAS:PBM) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Psyence Biomedical Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Psyence Biomedical's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Psyence Biomedical (Psyence Biomedical) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
121 Richmond Street West, Penthouse Suite 1300, Toronto, ON, CAN, M5H 2K1
Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed ISO22000 facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

Psyence Biomedical (Psyence Biomedical) Headlines